Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 15, 2024

BUY
$220.09 - $273.15 $424,993 - $527,452
1,931 New
1,931 $430,000
Q3 2023

Nov 14, 2023

BUY
$240.69 - $338.77 $128,769 - $181,241
535 Added 52.14%
1,561 $377,000
Q2 2023

Aug 14, 2023

BUY
$271.54 - $344.06 $278,600 - $353,005
1,026 New
1,026 $353,000
Q4 2022

Feb 14, 2023

BUY
$151.88 - $228.5 $151,728 - $228,271
999 New
999 $222,000
Q1 2022

May 16, 2022

BUY
$187.51 - $283.98 $187,510 - $283,980
1,000 New
1,000 $222,000
Q1 2021

May 17, 2021

SELL
$175.6 - $291.43 $323,104 - $536,231
-1,840 Closed
0 $0
Q4 2020

Feb 16, 2021

BUY
$174.98 - $272.83 $321,963 - $502,007
1,840 New
1,840 $322,000

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $10.3B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Two Sigma Securities, LLC Portfolio

Follow Two Sigma Securities, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Securities, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Securities, LLC with notifications on news.